Matches in SemOpenAlex for { <https://semopenalex.org/work/W3167678223> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W3167678223 endingPage "e18837" @default.
- W3167678223 startingPage "e18837" @default.
- W3167678223 abstract "e18837 Background: The CMS Oncology Care Model (OCM) aims to improve quality of care and health outcomes in cancer centers at the same or lower cost. We performed cost-efficiency analyses of converting selected cancer patients (pts) from reference pegfilgrastim (PFG) to its biosimilar (PFG-jmdb); and simulated re-allocating savings to provide nutrition and transportation support to CMS beneficiaries within OCM. Methods: Incidence rates for breast, ovarian, lung, colorectal cancers and non-Hodgkin lymphoma were extracted from SEER, further stratified by age <65 (commercial insurance) or >65 (Medicare) adjusted for Medicare/Medicaid mix. Chemotherapy (CTX) rates were matched to tumor type; of these 19.4% were assumed to require PFG prophylaxis (PPX). Two models compared respectively prefilled syringe (PFS) and on-body injector (OBI) reference PFG to PFS PFG-jmdb. Cost inputs included Average Sales Price (ASP) 3Q20 for Medicare and National Average Drug Acquisition Cost (NADAC, estimated by wholesale acquisition cost (WAC)-3.9%) for Medicaid pts plus medication administration. Cost savings across various biosimilar conversion rates for CTX cycles 1-6 were translated into $100 units of healthy food or medical transportation. Results: In 2020, biosimilar conversion for the estimated 31,210 Medicare and 1,722 Medicaid pts in the 5 tumor types needing PFG PPX yielded savings of up to ̃$19M (Medicare) and ̃$20M (Medicaid). These savings could have provided a monthly $100 food or transportation check to at least 24,716 Medicare or 33,630 Medicaid pts for 6 months. Conclusions: Savings from biosimilar conversion can be re-allocated on a budget neutral basis to food and transportation support to pts with such needs. This achieves the dual OCM aim of reducing drug budgets while enhancing patient-centric support services.[Table: see text]" @default.
- W3167678223 created "2021-06-22" @default.
- W3167678223 creator A5022744383 @default.
- W3167678223 creator A5031658471 @default.
- W3167678223 creator A5049387929 @default.
- W3167678223 creator A5090261710 @default.
- W3167678223 date "2021-05-20" @default.
- W3167678223 modified "2023-10-14" @default.
- W3167678223 title "Cost-efficiency analysis of conversion from reference pegfilgrastim to its biosimilar (pegfilgrastim-jmdb) and expanded access to food and transportation support for Medicare/Medicaid patients within the CMS Oncology Care Model." @default.
- W3167678223 doi "https://doi.org/10.1200/jco.2021.39.15_suppl.e18837" @default.
- W3167678223 hasPublicationYear "2021" @default.
- W3167678223 type Work @default.
- W3167678223 sameAs 3167678223 @default.
- W3167678223 citedByCount "2" @default.
- W3167678223 countsByYear W31676782232021 @default.
- W3167678223 countsByYear W31676782232023 @default.
- W3167678223 crossrefType "journal-article" @default.
- W3167678223 hasAuthorship W3167678223A5022744383 @default.
- W3167678223 hasAuthorship W3167678223A5031658471 @default.
- W3167678223 hasAuthorship W3167678223A5049387929 @default.
- W3167678223 hasAuthorship W3167678223A5090261710 @default.
- W3167678223 hasConcept C104863432 @default.
- W3167678223 hasConcept C126322002 @default.
- W3167678223 hasConcept C143998085 @default.
- W3167678223 hasConcept C160735492 @default.
- W3167678223 hasConcept C162324750 @default.
- W3167678223 hasConcept C2776534028 @default.
- W3167678223 hasConcept C2776694085 @default.
- W3167678223 hasConcept C2777767877 @default.
- W3167678223 hasConcept C2778658803 @default.
- W3167678223 hasConcept C2779171977 @default.
- W3167678223 hasConcept C2779703844 @default.
- W3167678223 hasConcept C50522688 @default.
- W3167678223 hasConcept C512399662 @default.
- W3167678223 hasConcept C59491497 @default.
- W3167678223 hasConcept C71924100 @default.
- W3167678223 hasConceptScore W3167678223C104863432 @default.
- W3167678223 hasConceptScore W3167678223C126322002 @default.
- W3167678223 hasConceptScore W3167678223C143998085 @default.
- W3167678223 hasConceptScore W3167678223C160735492 @default.
- W3167678223 hasConceptScore W3167678223C162324750 @default.
- W3167678223 hasConceptScore W3167678223C2776534028 @default.
- W3167678223 hasConceptScore W3167678223C2776694085 @default.
- W3167678223 hasConceptScore W3167678223C2777767877 @default.
- W3167678223 hasConceptScore W3167678223C2778658803 @default.
- W3167678223 hasConceptScore W3167678223C2779171977 @default.
- W3167678223 hasConceptScore W3167678223C2779703844 @default.
- W3167678223 hasConceptScore W3167678223C50522688 @default.
- W3167678223 hasConceptScore W3167678223C512399662 @default.
- W3167678223 hasConceptScore W3167678223C59491497 @default.
- W3167678223 hasConceptScore W3167678223C71924100 @default.
- W3167678223 hasIssue "15_suppl" @default.
- W3167678223 hasLocation W31676782231 @default.
- W3167678223 hasOpenAccess W3167678223 @default.
- W3167678223 hasPrimaryLocation W31676782231 @default.
- W3167678223 hasRelatedWork W12927781 @default.
- W3167678223 hasRelatedWork W17180406 @default.
- W3167678223 hasRelatedWork W18725558 @default.
- W3167678223 hasRelatedWork W189991172 @default.
- W3167678223 hasRelatedWork W19039903 @default.
- W3167678223 hasRelatedWork W19124980 @default.
- W3167678223 hasRelatedWork W2311732 @default.
- W3167678223 hasRelatedWork W518170 @default.
- W3167678223 hasRelatedWork W9411798 @default.
- W3167678223 hasRelatedWork W18754598 @default.
- W3167678223 hasVolume "39" @default.
- W3167678223 isParatext "false" @default.
- W3167678223 isRetracted "false" @default.
- W3167678223 magId "3167678223" @default.
- W3167678223 workType "article" @default.